Featured Posts

  

Dispatches From the Crossroads

Rss
Posted by: BIO Ventures for Global Health on 6/24/2011 | 0 Comments
If I had a bucket full of earthworms, you might think I was looking forward to a big day of fishing. But what if I told you that my bucket full of worms came from a person rather than my backyard? My bucket full of worms isn’t from just any person – it’s from a single child who never even knew he was infected.
Categories: News
Posted by: BIO Ventures for Global Health on 6/20/2011 | 0 Comments
Clearly, emerging markets are increasingly important players in the biotech industry. At next Monday’s Partnering for Global Health Forum, decision makers from emerging markets will come together at the Walter E. Washington Convention Center in Washington, DC, to discuss how the growing economic power of emerging economies can be combined with global health interests. Speakers include Dr. Maharaj K. Bhan, Secretary of the Department of Biotechnology of India; Dr. Bongi Gumede of South Africa's Technology Innovation Agency (TIA); Minister Lino Barañao of Argentina's Ministry of Science, Technology, and Innovative Production; Julio Ramundo, Director at the Brazilian Development Bank (BNDES); and G. Steven Burrill, CEO of Burrill & Company.
Categories: Meetings Partnering
Posted by: BIO Ventures for Global Health on 6/3/2011 | 0 Comments
In 2006, the Nobel Prize in Physiology or Medicine was awarded for the discovery of RNA interference (RNAi). This discovery fundamentally changed how scientists think about genes, opened the door to a new world of biological techniques to validate drug targets, and established the biological basis for a novel approach to disease treatments. So why is this discovery so important in global health research and development today?
Categories: Partnering

  

Recent Comments

by Chad on Coffee Break
"It is really sad that third-world countries suffer so much from an assortment of diseases and we tend to live without worrying about it. Only in a perfect world could the public and privates sectors work together as a "super-power" to recognize and fix these problems, but as of the current economic conditions it seems to be fading even more. Honestly, this is such a sad moment for everyone!" Read more »

by Yina on A Shifting Paradigm?
"As a long time agent of change in the Healthcare space, I have seen the under uliaizttion of technology. It is not bleeding edge' technology that causes me concern but the more mature ones that have been poorly driven and implemented. Much of this can be attributed to the Change Management plan. We fail to fully vet pilot sites, we jam data and processing into the pipe without taking avantage of future implementations, we include the directly affected stakeholders long after implementation starts and we don't analyze the impact on systems and layered products needed for success. The resourcing and uliaizttion of analysts, technical tactitions and workflow specialtists is arduous and expensive (and often considered unnecessary). However, the reengineering of applications and lost hours due to disruption at the user end needs to be added to the cost algorithm. After all even a medium sized system implementation failure creates grief for anyone else trying to affect change in the same user environment." Read more »

by Christian on Crossing the Valley of Death
"If the NIH could find a way to get the CAN funded then we could get some more research and development on the way. Congress just needs to approve the funding for this project. Thanks..." Read more »